AI assistant
NEKTAR THERAPEUTICS — Director's Dealing 2017
Sep 21, 2017
32134_dirs_2017-09-21_a546cdf0-e260-47d2-942b-f4ece546d63a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NEKTAR THERAPEUTICS (NKTR)
CIK: 0000906709
Period of Report: 2017-09-19
Reporting Person: Ajer Jeffrey Robert (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-09-19 | Common Stock | A | 13500 | $0.00 | Acquired | 13500 | Direct |
| 2017-09-19 | Common Stock | A | 9000 | $0.00 | Acquired | 22500 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-09-19 | Stock Option | $21.75 | A | 33750 | Acquired | 2025-09-18 | Common Stock (33750) | Direct |
| 2017-09-19 | Stock Option | $21.75 | A | 22500 | Acquired | 2025-09-18 | Common Stock (22500) | Direct |
Footnotes
F1: This stock award was acquired pursuant to a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive, upon vesting of the unit, one share of the issuer's common stock.
F2: This restricted stock unit award vests over three years in equal annual installments beginning on September 19, 2017.
F3: This restricted stock unit award vests in full, one year following September 19, 2017.
F4: This stock option vests in equal monthly installments over the three-year period beginning on September 30, 2017.
F5: This stock option vests in equal monthly installments over the one-year period beginning on September 30, 2017.